Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JULY 27, 2022

As a Schedule I substance under the Controlled Substances Act, marijuana has a high potential for abuse and no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. Food and Drug Administration (FDA) has federal authority to approve drugs for medicinal use in the U.S.

Marijuana 52

Marijuana DEA State Laws Policy 52

Cannabis Law Report

JULY 12, 2019

Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Fabricio A.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Info

MARCH 26, 2019

In 2005, this writer penned ‘The Real Reason Marijuana is Illegal’ and it became (by far) my most popular article. I feel that if it was taken off the list and proved to the DEA, FDA, or whoever else…that it isn’t a narcotic then we can get some headway on this wonderful, helpful plant. Unbelievable.

Marijuana 51

Marijuana Hemp Blood Pressure Oil 51